custom image

Advances in Cancer Immunotherapy

August 17–19, 2020 | 10:00AM EDT | 2:00PM UTC | 4:00PM CEST*
*Program is subject to change


Cancer immunotherapy provides unprecedented long-term antitumor activity in some patients, however, the majority of patients with advanced cancers only experience short-term remission. To achieve better outcomes for everyone will require understanding the mechanistic basis of response, and resistance, to these therapies (immune inhibitory checkpoint blockade and T-cell engineering), as well as how to best combine these therapeutic approaches for sustained clinical success.

In this virtual meeting we will tackle many of these unanswered questions in the field, including:

  • how do cancers adapt and resist T cell attack?
  • can we better understand the tumor microenvironment to pave the way for new approaches to immunotherapy?
  • what is the rationale behind immune-oncology (IO) combinations in clinical testing?

The program will highlight novel methodologies, data-analysis techniques, and tools to integrate high throughput and patient-derived sample data-- revealing powerful new approaches to understand both genetic and adaptive resistance mechanisms, and ways to overcome them. The largest human experiment to date is currently underway, with over 1,000 agents and combinations being tested; examining preliminary results will be key to refining our approaches, and understanding of immunity in patients with cancer.

Overall participants will gain a more comprehensive understanding of tumor immunology, and how to leverage this knowledge to outsmart tumors and achieve lasting remission in patients. In addition, the virtual event provides a platform for junior researchers and rising starts in the field to share promising new directions that will lead the field forward towards new and innovative breakthroughs.

Held in honor of cancer immunotherapy research pioneers Dr. Alan Korman and Dr. Nils Lonberg, thanks to generous support from an anonymous donor.

Program is intended for scientific researchers and clinical audiences.

Join us for this landmark virtual event, brought to you by Keystone Symposia.

Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD

#VKScancerimmuno20

     



Scholarship Opportunities


Scholarships for discounted registration will be offered to qualifying students and postdoctoral fellows, as well as scientists from low- and middle-income countries (of all career stages), who are interested in presenting their work. Details will be available soon. Subscribe to receive updates on scholarship opportunities for this meeting.


Email address:    




Program Details



Editors Attending This Meeting


custom image custom image
Gaia Trincucci, PhD Scientific Editor, Journal of Experimental Medicine (JEM)
Teodoro-Pulvirenti, PhD Executive Editor, Journal of Experimental Medicine (JEM)
Speaking at this eSymposia


James P. Allison

University of Texas MD Anderson Cancer Center


Coralie Backlund

Massachusetts Institute of Technology

Anthony S. Fauci, MD

Matthias Braun

QIMR Berghofer


Amanda Campbell

Nationwide Children's Hospital



Yvonne Y. Chen

University of California, Los Angeles


Shira Cherny

University of Washington


AHyun Choi

Novartis Institutes for BioMedical Research


Kelli Connolly

Yale University


Nadine A. Defranoux

Parker Institute for Cancer Immunotherapy


W. Nicholas Haining

Merck Research Laboratories


James R. Heath

Institute for Systems Biology


Priti Hegde

Foundation Medicine


Maija Hollmén

University of Turku

Gabriel D. Victora

Siwen Hu-Lieskovan

Huntsman Cancer Institute


Juan C. Jaen

Arcus Biosciences, Inc.


Vandana Kalia

University of Washington


Yeon Joo Kim

University of California, Los Angeles

Gabriel D. Victora

Gloria Bora Kim

University of Pennsylvania


Alan J. Korman

Vir Biotechnology, Inc.


Puay Ling Lee

Francis Crick Institute


James C. Lee

University of California, San Francisco

Gabriel D. Victora

Chang Liu

University of Pittsburgh


Nils Lonberg

Canaan Partners


Georgina V. Long

Melanoma Institute Australia, The University of Sydney


Zoila Areli Lopez Bujanda

Johns Hopkins University

Gabriel D. Victora

Crystal L. Mackall

Stanford University


Elaine R. Mardis

Nationwide Children's Hospital


Ira Mellman

Genentech, Inc.


Yuxuan Miao

Rockefeller University

Gabriel D. Victora

Stephen Mok

MD Anderson Cancer Center


Christine Carine Moussion

Genentech, Inc.


Jane Oliaro

Peter MacCallum Cancer Centre


Amanda Oliver

Peter MacCallum Cancer Centre

Gabriel D. Victora

Patrick A. Ott

Dana-Farber Cancer Institute


Anthony K. Park

City of Hope


Vanessa Peterson

Merck


Buvana Ravishankar

Rapt Therapeutics, Inc.

Gabriel D. Victora

Antoni Ribas

University of California, Los Angeles


Theodore Roth

University of California, San Francisco


Ansuman Satpathy

Stanford University School of Medicine


Robert D. Schreiber

Washington University School of Medicine

Gabriel D. Victora

Evan Scott

Northwestern University


Debattama Sen

Harvard Medical School


Padmanee Sharma

University of Texas MD Anderson Cancer Center


Sohail F. Tavazoie

Rockefeller University

Gabriel D. Victora

Eliezer M. Van Allen

Dana-Farber Cancer Institute


Yingxiao Wang

University of California, San Diego


E. John Wherry

University of Pennsylvania

Gabriel D. Victora

Thomas D. Wu

Genentech, Inc.

 
 
 
     




Sponsors



custom image
custom image
custom image
custom image
custom image
custom image
custom image
custom image
custom image
 
custom image
 

Funding for this conference was made possible (in part) by 1R13AI150086-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.





The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.






Related Keystone Symposia In-Person Meetings

Explore all cancer-related meetings on the Keystone Symposia website.

custom image
custom image
custom image






Donate to Keystone Symposia


custom image